Immunotherapy for Myeloproliferative Neoplasms (MPN)

E-ISSN： 1873-5576|11|1|72-84

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 72-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting JAK2 in the therapy of myeloproliferative neoplasms

By Reddy Mamatha M Deshpande Anagha Sattler Martin

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 313-324

Informa Healthcare

Access to resources Recommend Favorite

Janus kinase inhibitors for the treatment of myeloproliferative neoplasms

By Rosenthal Allison Mesa Ruben A

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1265-1276

Informa Healthcare

Access to resources Recommend Favorite

JAK2 inhibitors in the treatment of myeloproliferative neoplasms

By Tibes Raoul Bogenberger James M Geyer Holly L Mesa Ruben A

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1755-1774

Informa Healthcare

Access to resources Recommend Favorite

New JAK2 inhibitors for myeloproliferative neoplasms

By Quintáás-Cardama Alfonso Verstovsek Srdan

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 961-972

Informa Healthcare

Access to resources Recommend Favorite

Comprehensively understanding fatigue in patients with myeloproliferative neoplasms

By Scherber Robyn M. Kosiorek Heidi E. Senyak Zhenya Dueck Amylou C. Clark Matthew M. Boxer Michael A. Geyer Holly L. McCallister Archie Cotter Mary Van Husen Barbara Harrison Claire N. Mesa Ruben A.

Cancer, Vol. 122, Iss. 3, 2016-02 ,pp. : 477-485

Blackwell Publishing

Access to resources Recommend Favorite